X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1451) 1451
Book Review (333) 333
Publication (65) 65
Book Chapter (8) 8
Book / eBook (7) 7
Conference Proceeding (3) 3
Magazine Article (3) 3
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1363) 1363
humans (832) 832
glycoside hydrolase inhibitors (621) 621
animals (518) 518
male (380) 380
hypoglycemic agents - therapeutic use (350) 350
diabetes mellitus, type 2 - drug therapy (317) 317
biochemistry & molecular biology (272) 272
female (270) 270
pharmacology & pharmacy (247) 247
enzyme inhibitors - therapeutic use (232) 232
chemistry, medicinal (223) 223
acarbose (221) 221
rats (212) 212
enzyme inhibitors - pharmacology (209) 209
glycoside hydrolase inhibitors - pharmacology (207) 207
enzymes (197) 197
glycoside hydrolases - metabolism (197) 197
alpha-glucosidases - metabolism (195) 195
diabetes (187) 187
mice (187) 187
hypoglycemic agents - pharmacology (182) 182
middle aged (179) 179
alpha-glucosidase (174) 174
blood glucose - metabolism (165) 165
plant extracts - pharmacology (156) 156
glycoside hydrolases - antagonists & inhibitors (146) 146
α-glucosidase (141) 141
endocrinology & metabolism (135) 135
1-deoxynojirimycin - analogs & derivatives (131) 131
adult (129) 129
glycoside hydrolase inhibitors - therapeutic use (126) 126
enzyme inhibitors - chemistry (123) 123
aged (122) 122
structure-activity relationship (117) 117
glycoside hydrolase inhibitors - chemistry (115) 115
molecular structure (115) 115
plant extracts - chemistry (111) 111
sulfonylurea compounds - therapeutic use (107) 107
type 2 diabetes (106) 106
analysis (105) 105
alpha-amylases - antagonists & inhibitors (103) 103
chemistry, organic (103) 103
glucose (101) 101
acarbose - therapeutic use (100) 100
dose-response relationship, drug (100) 100
diabetes mellitus, type 2 - blood (99) 99
alpha-glucosidase inhibitor (93) 93
kinetics (91) 91
blood glucose - drug effects (88) 88
glucosidase (88) 88
plant sciences (88) 88
research (87) 87
diabetes mellitus (86) 86
insulin (86) 86
in-vitro (84) 84
diabetes mellitus - drug therapy (83) 83
insulin - therapeutic use (83) 83
proteins (83) 83
hypoglycemic agents - chemistry (80) 80
inhibitors (80) 80
insulin - blood (79) 79
hyperglycemia (78) 78
inhibition (78) 78
chemistry, applied (77) 77
trisaccharides - therapeutic use (77) 77
time factors (76) 76
treatment outcome (76) 76
hyperglycemia - drug therapy (75) 75
biotechnology & applied microbiology (74) 74
models, molecular (74) 74
glycosides (73) 73
derivatives (72) 72
drug therapy, combination (72) 72
hypoglycemic agents - administration & dosage (72) 72
phytotherapy (72) 72
antioxidants (71) 71
glycosylation (70) 70
research article (70) 70
blood glucose - analysis (69) 69
mellitus (69) 69
metformin - therapeutic use (69) 69
alpha-glucosidase inhibitors (68) 68
α-glucosidase inhibitor (68) 68
diabetes mellitus, experimental - drug therapy (66) 66
antioxidants - pharmacology (65) 65
glycoside hydrolases - chemistry (65) 65
hypoglycemic agents - adverse effects (65) 65
article (64) 64
food science & technology (64) 64
plant extracts - therapeutic use (64) 64
administration, oral (62) 62
alpha-glucosidases - chemistry (62) 62
oxidative stress (62) 62
glycoside hydrolase inhibitors - isolation & purification (60) 60
medicine, research & experimental (60) 60
flavonoids (59) 59
integrative & complementary medicine (59) 59
postprandial hyperglycemia (59) 59
1-deoxynojirimycin - therapeutic use (58) 58
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1374) 1374
Japanese (35) 35
French (21) 21
German (9) 9
Russian (5) 5
Spanish (5) 5
Italian (4) 4
Finnish (2) 2
Hebrew (2) 2
Chinese (1) 1
Croatian (1) 1
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Hungarian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Medicinal Chemistry, ISSN 0022-2623, 04/2018, Volume 61, Issue 8, pp. 3609 - 3625
Journal Article
DIABETES CARE, ISSN 0149-5992, 01/2018, Volume 41, Issue 1, pp. 14 - 31
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 07/2014, Volume 13, Issue 1, pp. 110 - 110
Background: Alpha glucosidase inhibitor (GI) attenuates postprandial hyperglycemia (PPH) and reduces the risk of cardiovascular events in patients with... 
Dipeptidyl peptidase 4 (DPP-4) inhibitors | Endothelial function | Flow-mediated dilatation | Alpha glucosidase inhibitor | CD34 | PROGENITOR CELLS | DIPEPTIDYL PEPTIDASE-4 INHIBITOR | GLYCEMIC CONTROL | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | VASCULAR-DISEASE | FLOW-MEDIATED VASODILATION | GLUCAGON-LIKE PEPTIDE-1 | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | JAPANESE PATIENTS | CORONARY-ARTERY-DISEASE | Prospective Studies | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Endothelium, Vascular - drug effects | Glycoside Hydrolase Inhibitors - therapeutic use | Male | Pyrazines - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Endothelium, Vascular - physiology | Young Adult | Inositol - therapeutic use | Aged, 80 and over | Adult | Female | Sitagliptin Phosphate | Triazoles - therapeutic use | Inositol - pharmacology | Glycoside Hydrolase Inhibitors - pharmacology | Inositol - analogs & derivatives | Triazoles - pharmacology | Diabetes Mellitus, Type 2 - diagnosis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Pyrazines - pharmacology | Urine | Oxidative stress | Peptides | Internal medicine | Colleges & universities | Cardiovascular disease | Dentistry | Medicine | Hyperglycemia | Hospitals | Coronary vessels | Diabetes | Acute coronary syndromes | Drug dosages | Pharmaceutical sciences | Pharmaceuticals | Index Medicus
Journal Article
Journal Article
Antiviral Research, ISSN 0166-3542, 05/2016, Volume 129, pp. 93 - 98
The antiviral activity of UV-4 was previously demonstrated against dengue virus serotype 2 (DENV2) in multiple mouse models. Herein, step-wise minimal... 
Antiviral | Iminosugar | Antibody-dependent enhancement | Glucosidase | Dengue | UV-4B | GLYCOLIPID BIOSYNTHESIS | VIRUS | OLIGOSACCHARIDES | GLYCOSYLATION | MOUSE MODELS | VIROLOGY | CELGOSIVIR | INTERFERON RECEPTOR | DEFICIENT | PHARMACOLOGY & PHARMACY | INFECTION | FEVER | Humans | Cercopithecus aethiops | Drugs, Investigational | Glycoside Hydrolase Inhibitors - therapeutic use | Antibodies, Viral - blood | 1-Deoxynojirimycin - therapeutic use | Endoplasmic Reticulum - drug effects | 1-Deoxynojirimycin - administration & dosage | Inhibitory Concentration 50 | 1-Deoxynojirimycin - analogs & derivatives | Antibody-Dependent Enhancement - drug effects | Vero Cells | Disease Models, Animal | Endoplasmic Reticulum - enzymology | Antiviral Agents - pharmacology | Dengue Virus - drug effects | Antiviral Agents - therapeutic use | Receptors, Interferon - deficiency | Cells, Cultured | Serogroup | Clinical Trials as Topic | Glycoside Hydrolase Inhibitors - chemistry | Glycoside Hydrolase Inhibitors - pharmacology | Antiviral Agents - administration & dosage | Glycoside Hydrolase Inhibitors - administration & dosage | Monocytes - virology | 1-Deoxynojirimycin - pharmacology | Animals | Severe Dengue - virology | Mice | Severe Dengue - drug therapy | alpha-Glucosidases - metabolism | Viral antibodies | Enzymes | Analysis | Communicable diseases | Dengue viruses | Antibodies | Interferon | Biological response modifiers | Health aspects | Medical research | Medicine, Experimental | Index Medicus | Short Communication
Journal Article
Journal Article
Journal Article
The Journal of Nutritional Biochemistry, ISSN 0955-2863, 09/2017, Volume 47, pp. 86 - 93
Dietary polyphenols have been shown to inhibit α-glucosidase, an enzyme target of some antidiabetic drugs. Resveratrol, a polyphenol found in grapes and wine,... 
Obesity | Stilbenes | α-Glucosidase | Resveratrol | Diabetes | 3′-Hydroxypterostilbene | Piceatannol | CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | 3 '-Hydroxypterostilbene | PTEROSTILBENE | CANCER | BETA | PROTECTS | IN-VITRO | STILBENE | NUTRITION & DIETETICS | alpha-Glucosidase | RED WINE | DERIVATIVES | CONSTITUENTS | Acarbose - pharmacology | Obesity - diet therapy | Obesity - drug therapy | Stilbenes - therapeutic use | Hypoglycemic Agents - metabolism | Glycoside Hydrolase Inhibitors - metabolism | Intestinal Absorption - drug effects | Starch - metabolism | Diet, High-Fat - adverse effects | Glycoside Hydrolase Inhibitors - therapeutic use | Starch - adverse effects | Stilbenes - metabolism | Dietary Carbohydrates - metabolism | Postprandial Period | Dietary Sucrose - metabolism | Hypoglycemic Agents - therapeutic use | Acarbose - therapeutic use | Hyperglycemia - prevention & control | Blood Glucose - analysis | Mice, Inbred C57BL | Rats | Obesity - physiopathology | Random Allocation | Glycoside Hydrolase Inhibitors - pharmacology | Hypoglycemic Agents - pharmacology | Obesity - metabolism | Gastrointestinal Agents - pharmacology | Animals | Dietary Carbohydrates - antagonists & inhibitors | Gastrointestinal Agents - therapeutic use | Dietary Sucrose - adverse effects | Hyperglycemia - etiology | Kinetics | alpha-Glucosidases - metabolism | Gastrointestinal Agents - metabolism | alpha-Glucosidases - chemistry | Index Medicus
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2014, Volume 16, Issue 8, pp. 761 - 765
We assessed the efficacy and safety of sitagliptin compared with α‐glucosidase inhibitor ( αGI ) in 120 of Japanese patients with type 2 diabetes mellitus (... 
type 2 diabetes | DPP‐IV | inhibitor | sulphonylureas | α‐glucosidase inhibitor | randomized trial | Type 2 diabetes | Randomized trial | α-glucosidase inhibitor | Sulphonylureas | DPP-IV inhibitor | VOGLIBOSE | MONOTHERAPY | HYPERGLYCEMIA | DOUBLE-BLIND TRIAL | alpha-glucosidase inhibitor | ENDOCRINOLOGY & METABOLISM | MELLITUS | Glycated Hemoglobin A - analysis | Triazoles - adverse effects | Glycoside Hydrolase Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Glycoside Hydrolase Inhibitors - therapeutic use | Male | Pyrazines - therapeutic use | Hypoglycemia - prevention & control | 1-Deoxynojirimycin - therapeutic use | Drug Therapy, Combination - adverse effects | Inositol - therapeutic use | Inositol - adverse effects | 1-Deoxynojirimycin - analogs & derivatives | Female | 1-Deoxynojirimycin - adverse effects | Sitagliptin Phosphate | Hypoglycemia - chemically induced | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Japan | Sulfonylurea Compounds - therapeutic use | Inositol - analogs & derivatives | Diabetes Mellitus, Type 2 - blood | Gastrointestinal Agents - therapeutic use | Pyrazines - adverse effects | Aged | Gastrointestinal Agents - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | alpha-Glucosidases - metabolism | alpha-Glucosidases - chemistry | Index Medicus
Journal Article
Journal Article
Journal Article